Literature DB >> 8229222

Effect of motion on thallium-201 SPECT studies: a simulation and clinical study.

F M Prigent1, M Hyun, D S Berman, A Rozanski.   

Abstract

Although patient motion on 201Tl SPECT studies has been reported as a source of artifacts, systematic studies on motion patterns and resultant artifacts are lacking. Accordingly, we simulated 74 motion patterns upon a normal study. The tomograms were assessed for presence of defects: The "motion pixel area index" ranged from 1 to 83; 26 of 30 (87%) simulations with an index > or = 21 had defects, whereas 38 of 44 (86%) simulations with an index < 21 were normal. Defect location was dependent on motion direction; defect intensity was dependent on its magnitude and timing. Review of data acquisition in 164 recent normal patient studies revealed motion in 42 (26%). Motion was generally minimal and caused defects in only seven (4%). Thus, mild motion is unlikely to produce defects. In our laboratory, motion is now an infrequent source of artifacts; severe motion produces recognizable patterns that depend on its direction, magnitude and timing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229222

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  24 in total

1.  Development of respiratory gated myocardial SPECT system.

Authors:  K Cho; S Kumiata; S Okada; T Kumazaki
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

Review 2.  Effect of motion on cardiac SPECT imaging: recognition and motion correction.

Authors:  J Fitzgerald; P G Danias
Journal:  J Nucl Cardiol       Date:  2001 Nov-Dec       Impact factor: 5.952

3.  Use of rotating (cine) planar projection images in the interpretation of a tomographic myocardial perfusion study.

Authors:  R C Hendel; R J Gibbons; T M Bateman
Journal:  J Nucl Cardiol       Date:  1999 Mar-Apr       Impact factor: 5.952

4.  Estimation of Rigid-Body and Respiratory Motion of the Heart From Marker-Tracking Data for SPECT Motion Correction.

Authors:  Joyeeta Mitra Mukherjee; Joseph E McNamara; Karen L Johnson; Joyoni Dey; Michael A King
Journal:  IEEE Trans Nucl Sci       Date:  2009-02       Impact factor: 1.679

5.  A study to quantify the effect of patient motion and develop methods to detect and correct for motion during myocardial perfusion imaging on a CZT solid-state dedicated cardiac camera.

Authors:  Shelley Redgate; David C Barber; John W Fenner; Abdallah Al-Mohammad; Jonathon C Taylor; Michael B Hanney; Wendy B Tindale
Journal:  J Nucl Cardiol       Date:  2015-12-18       Impact factor: 5.952

6.  Use of three-dimensional Gaussian interpolation in the projector/backprojector pair of iterative reconstruction for compensation of known rigid-body motion in SPECT.

Authors:  Bing Feng; Howard C Gifford; Richard D Beach; Guido Boening; Michael A Gennert; Michael A King
Journal:  IEEE Trans Med Imaging       Date:  2006-07       Impact factor: 10.048

Review 7.  Optimal SPECT processing and display: making bad studies look good to get the right answer.

Authors:  Dalia Y Ibrahim; Frank P DiFilippo; Jeremy E Steed; Manuel D Cerqueira
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

8.  Estimation of the Rigid-Body Motion from Three-Dimensional Images Using a Generalized Center-of-Mass Points Approach.

Authors:  B Feng; P P Bruyant; P H Pretorius; R D Beach; H C Gifford; J Dey; M Gennert; M A King
Journal:  IEEE Trans Nucl Sci       Date:  2006-10       Impact factor: 1.679

9.  Use of MRI to assess the prediction of heart motion with gross body motion in myocardial perfusion imaging by stereotracking of markers on the body surface.

Authors:  Michael A King; Joyoni Dey; Karen Johnson; Paul Dasari; Joyeeta M Mukherjee; Joseph E McNamara; Arda Konik; Cliff Lindsay; Shaokuan Zheng; Dennis Coughlin
Journal:  Med Phys       Date:  2013-11       Impact factor: 4.071

10.  Use of the selective linogram in cardiac tomography quality control.

Authors:  J W Wallis
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.